# Emergent BioSolutions Inc.: Form 8-K, filed Jun 7, 2022

- Company: [Emergent BioSolutions Inc.](/companies/ebs.md) (CIK 1367644)
- Form: 8-K
- Filed: 2022-06-07
- Accepted by EDGAR: Jun 7, 2022, 06:43 ET
- Period: 2022-06-06
- Accession: 0001367644-22-000099
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1367644/000136764422000099/ebs-20220606.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1367644/000136764422000099/

## Items reported

- Item 1.02: Termination of a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1367644/000136764422000099/ebs-20220606.htm

Filed Jun 7, 2022.
Source: SEC EDGAR, the filing index for accession 0001367644-22-000099. Last ingested by Listed: Nov 4, 2026, 16:51 ET. No prices; not investment advice.
